Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations

BACKGROUND: Decreases in the bioavailability of rifampicin (RFP) can lead to the development of drug resistance and treatment failure. Therefore, we investigated the relative bioavailability of RFP from one four-drug fixed-dose combination (FDC; formulation A) and three two-drug FDCs (formulations B...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hui, Guo, Shao-Chen, Hao, Lan-Hu, Liu, Cheng-Cheng, Wang, Bin, Fu, Lei, Chen, Ming-Ting, Zhou, Lin, Chi, Jun-Ying, Yang, Wen, Nie, Wen-Juan, Lu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836242/
https://www.ncbi.nlm.nih.gov/pubmed/25673441
http://dx.doi.org/10.4103/0366-6999.151061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836242/
https://www.ncbi.nlm.nih.gov/pubmed/25673441
http://dx.doi.org/10.4103/0366-6999.151061

Ejemplares similares